Anika Therapeutics ANIK Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

GATXGATX

$1.75M+243%

CarGurus, Inc.CARG

-$613K-186%

ADTRAN Holdings, Inc.ADTN

-$2.56M-2,024%

Achieve Life SciencesACHV

$4K—

Franklin CoveyFC

$205K—

SPS CommerceSPSC

$288K-56.4%

Other financials

Income statement

See full

Revenue$29.6M+13.2%

Net income-$5.1M-3.8%

Balance sheet

See full

Cash & equivalents$41.0M-23.1%

Total debt$25.7M+1.2%

Total equity$133.9M-9.8%

Total assets$179.4M-5.9%

Cash flow

See full

Operating cash flow-$4.8M-3,628%

CapEx$1.4M-49.3%

Free cash flow-$6.3M-112%

Valuation

See full

Market cap$204.37M+31.6%

Enterprise value$189.09M+48.7%

P/S1.8×+0.1×

Profitability

See full

Net margin-9.8%-4.4pp

FCF margin0.9%—

Returns & leverage

See full

Return on equity-8%-3.4pp

Debt / equity0.2×0.0×

Current ratio4.5×-1.3×

Where this comes from

Reported directly by Anika Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Anika Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Anika Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?: Anika Therapeutics (ANIK) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of -$29K in Q1 2026.
How has Anika Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?: Anika Therapeutics's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash decreased by 126.9% year-over-year, from $108K to -$29K.